Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05669716 · ClinicalTrials.gov registry record

Adolescent Vaping Characterization and Parent Views on Adolescent Vaping Protocol

A clinical trial, sponsored by National Institute on Drug Abuse (NIDA).

Terminated
Registry status
726
Enrollment target

NCT05669716 is a clinical trial that was terminated before completion, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 726 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05669716 was terminated before completion, sponsored by National Institute on Drug Abuse (NIDA).

TERMINATED
Registry status
726 participants
Enrollment target

Study Summary

Background: The use of electronic cigarettes (vaping) has increased among adolescents over the past decade. Vaping raises many health concerns. People who vape inhale toxic chemicals. Vaping is also linked with mental health issues, such as depression and suicide risk. In one survey, 85% of young adults reported that they used both vaping and tobacco products; the primary reason they cited for using these products was stress. Objective: This natural history study will survey adolescents and their parents about their attitudes toward vaping. Eligibility: People aged 13 to 18, including those who vape; those who once vaped; and those who have never vaped. Parents of people aged 13 to 18 who are known or suspected of vaping are also needed. Design: Participants will take a survey. They will use their own smartphone, computer, or tablet to answer questions. The survey will take about 20 minutes. Their answers will be anonymous. Teenage participants will answer questions on different topics: Vaping habits, such as when and how they vape. Drug use, including nicotine, cannabis, and alcohol. Mood issues, such as depression, anxiety, and stress. Social influences on vaping, including perceived attitudes of parents and peers. Other leisure habits, including online gaming and use of social media. Parents will answer similar questions. A phone number and links will be given to participants who need help for suicidal thoughts. Other links will be given to those who want help with parenting resources or aids to quit vaping. Participants may be invited to take part in an 8-week course on mindfulness-based stress reduction. Participants who finish the survey will receive 10 dollars. ...

Trial Details

FieldValue
Enrollment Target 726 participants
Start Date 2023-03-09
Est. Completion 2025-09-25

What the Registry Record Tells You About NCT05669716

The ClinicalTrials.gov registry entry for NCT05669716 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 726 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT05669716 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05669716 about?

NCT05669716 is a clinical study titled "Adolescent Vaping Characterization and Parent Views on Adolescent Vaping Protocol". Background: The use of electronic cigarettes (vaping) has increased among adolescents over the past decade. Vaping raises many health concerns. People who vape inhale toxic chemicals. Vaping is also linked with mental health issues, such as depression and suicide risk. In one survey, 85% of young a...

What is the current status of trial NCT05669716?

This trial is currently terminated. The enrollment target is 726 participants. The study started on 2023-03-09. Estimated completion is 2025-09-25.

Who is sponsoring clinical trial NCT05669716?

This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.